Emily Rakestraw

ORCID: 0009-0003-9356-5704
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Cells and Metastasis
  • Cancer Immunotherapy and Biomarkers
  • Aortic aneurysm repair treatments
  • Peripheral Artery Disease Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiovascular Health and Disease Prevention
  • Immunotherapy and Immune Responses
  • Cutaneous Melanoma Detection and Management
  • CAR-T cell therapy research
  • Coronary Interventions and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cardiovascular Function and Risk Factors

Duke University
2024-2025

Chronic limb-threatening ischemia (CLTI) is one of the leading causes permanent disability and death in United States around world. Surgical revascularization mainstay treatment for CLTI, but patients still suffer high rates limb loss early death, even compared to other cardiovascular diseases. One significant reason this difficulty accurately predicting whether a planned intervention will, fact, improve distal blood flow as hoped. Given need, we have introduced an angiography-based...

10.1109/embc53108.2024.10781932 article EN 2024-07-15
Coming Soon ...